News
For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.
Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type ...
Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, according to new research ...
A new study suggests that this side effect of drugs like Ozempic may relieve men of the surprising ailment that affects ...
2d
MedPage Today on MSNMenopause Hormone Therapy Users May Lose More on Weight Loss InjectableAmong 120 women with overweight or obesity, MHT users lost 19.18% of their total body weight with tirzepatide (Mounjaro, Zepbound) compared with a 13.96% loss in women not on such therapy after an ...
Eli Lilly’s Zepbound transformed weight loss drug market since debut 18 months ago 4.5 million people reportedly taking Lilly ...
Bariatric Surgery vs. Weight-Loss Drugs: What Science Says About Effective Weight Loss with Diabetes
Struggling to lose weight with diabetes? Find out what science says about bariatric surgery vs. weight-loss drugs—and which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results